Cargando…
Malignant tumor is the greatest risk factor for pulmonary embolism in hospitalized patients: a single-center study
BACKGROUND: This study aimed to investigate the background of patients who presented with pulmonary embolism (PE) on contrast-enhanced chest computed tomography (CT) and to explore the risk factors for PE. METHODS: This study included a review of the medical records of all 50,621 patients who were a...
Autores principales: | Fujieda, Kaoru, Nozue, Akiko, Watanabe, Akie, Shi, Keiko, Itagaki, Hiroya, Hosokawa, Yoshihiko, Nishida, Keiko, Tasaka, Nobutaka, Satoh, Toyomi, Nishide, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557488/ https://www.ncbi.nlm.nih.gov/pubmed/34717649 http://dx.doi.org/10.1186/s12959-021-00334-2 |
Ejemplares similares
-
Abnormal accumulation of p53 predicts radioresistance leading to poor survival in patients with endometrial carcinoma
por: Akiyama, Azusa, et al.
Publicado: (2019) -
Preoperative Venous Thromboembolism Screening and Postoperative Selective Anticoagulant Therapy Effectively Prevents Postoperative Symptomatic Venous Thromboembolism in Gynecological Malignancies: A 15-Year, Single-Center Study
por: Tasaka, Nobutaka, et al.
Publicado: (2023) -
Cellular angiofibroma in the retroperitoneal space during pregnancy: A case report
por: Abe, Hanae, et al.
Publicado: (2023) -
Pretreatment thrombocytosis as an independent predictive factor for chemoresistance and poor survival in epithelial ovarian cancer
por: Nakao, Sari, et al.
Publicado: (2020) -
Differential roles of the Wip1–p38–p53 DNA damage response pathway in early/advanced-stage ovarian clear cell carcinomas
por: Xu, Chenyang, et al.
Publicado: (2022)